Acute Gaucher Disease-Like Condition in an Indian Infant with a Novel Biallelic Mutation in the Prosaposin Gene

Abstract

This is the first reported case of prosaposin (PSAP) mutation from India manifesting as an acute neuronal Gaucher disease-like condition. A 2-month-old male baby presented with encephalopathy, resistant tonic–clonic seizures, moderate hepatosplenomegaly, hypotonia, and cherry red spot in the retinae. The child had anemia, thrombocytopenia, elevated chitotriosidase, and normal activity of acid sphingomyelinase and low normal activity of β-glucosidase 1 (β-glucocerebrosidase 1, GBA). The child succumbed in the fourth month of life due to persistent respiratory distress and refractory seizures. The clinical phenotype, cherry red spots, elevated chitotriosidase, and lysosomal assays led to the suspicion of Gaucher disease. Exome sequencing revealed a homozygous stop codon mutation in the PSAP gene (c.G1228T, p.Glu410ter). Prenatal diagnosis in the next pregnancy revealed a carrier fetus, who was unaffected postnatally. The diagnosis of specific activator deficiency such as saposin C and saposin D deficiency (in the current study) should be considered and tested for when Gaucher disease is suspected in an infant with partially deficient or near normal GBA activity.

Keywords

prosaposin - specific activator deficiency - neuronopathic Gaucher disease

• References

• 1 Razek AAKA, Abdalla A, Barakat T, El-Taher H, Ali K. Assessment of the liver and spleen in children with Gaucher disease type I with diffusion-weighted MR imaging. Blood Cells Mol Dis 2018; 68: 139-142
• 2 Razek AA, Abdalla A, Gaber NA. , et al. Proton MR Spectroscopy of the brain in children with neuronopathic Gaucher's disease. Eur Radiol 2013; 23 (11) 3005-3011
• 3 Razek AA, Abdalla A, Fathy A, Megahed A. Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III. Skeletal Radiol 2013; 42 (02) 283-287
• 4 Razek AAKA, Abdalla A, Barakat T, El-Taher H, Ali K. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease. Clin Imaging 2018; 51: 318-322
• 5 Abdel Razek AA, Abd El-Gaber N, Abdalla A, Fathy A, Azab A, Rahman AA. Apparent diffusion coefficient vale of the brain in patients with Gaucher's disease type II and type III. Neuroradiology 2009; 51 (11) 773-779
• 6 Cormand B, Montfort M, Chabás A, Vilageliu L, Grinberg D. Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease. Hum Genet 1997; 100 (01) 75-79
• 7 Schnabel D, Schröder M, Sandhoff K. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett 1991; 284 (01) 57-59
• 8 Rafi MA, de Gala G, Zhang XL, Wenger DA. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat Cell Mol Genet 1993; 19 (01) 1-7
• 9 Diaz-Font A, Cormand B, Santamaria R, Vilageliu L, Grinberg D, Chabás A. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity. Hum Genet 2005; 117 (2–3): 275-277
• 10 Hulková H, Cervenková M, Ledvinová J. , et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 2001; 10 (09) 927-940
• 11 Tylki-Szymańska A, Czartoryska B, Vanier MT. , et al. Non-neuronopathic Gaucher disease due to saposin C deficiency. Clin Genet 2007; 72 (06) 538-542
• 12 Vaccaro AM, Motta M, Tatti M. , et al. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting. Hum Mol Genet 2010; 19 (15) 2987-2997
• 13 Kang L, Zhan X, Ye J. , et al. A rare form of Gaucher disease resulting from saposin C deficiency. Blood Cells Mol Dis 2018; 68: 60-65
• 14 Guo Y, He W, Boer AM. , et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 1995; 18 (06) 717-722
• 15 Daniels LB, Glew RH, Diven WF, Lee RE, Radin NS. An improved fluorometric leukocyte β-glucosidase assay for Gaucher's disease. Clin Chim Acta 1981; 115 (03) 369-375
• 16 van Diggelen OP, Voznyi YV, Keulemans JLM. , et al. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. J Inherit Metab Dis 2005; 28 (05) 733-741
• 17 Kadali S, Kolusu A, Sunkara S, Gummadi MR, Undamatla J. Clinical evaluation of chitotriosidase enzyme activity in Gaucher and Niemann Pick A/B diseases: a retrospective study from India. Clin Chim Acta 2016; 457: 8-11
• 18 Klein A, Henseler M, Klein C, Suzuki K, Harzer K, Sandhoff K. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo. Biochem Biophys Res Commun 1994; 200 (03) 1440-1448
• 19 Matsuda J, Kido M, Tadano-Aritomi K. , et al. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum Mol Genet 2004; 13 (21) 2709-2723
• 20 Bradová V, Smíd F, Ulrich-Bott B, Roggendorf W, Paton BC, Harzer K. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum Genet 1993; 92 (02) 143-152
• 21 Sun Y, Witte DP, Zamzow M. , et al. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking. Hum Mol Genet 2007; 16 (08) 957-971
• 22 Sun Y, Ran H, Zamzow M. , et al. Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse. Hum Mol Genet 2010; 19 (04) 634-647
• 23 Motta M, Camerini S, Tatti M. , et al. Gaucher disease due to saposin C deficiency is an inherited lysosomal disease caused by rapidly degraded mutant proteins. Hum Mol Genet 2014; 23 (21) 5814-5826
• 24 Motta M, Tatti M, Furlan F. , et al. Clinical, biochemical and molecular characterization of prosaposin deficiency. Clin Genet 2016; 90 (03) 220-229
• 25 Vitner EB, Dekel H, Zigdon H. , et al. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum Mol Genet 2010; 19 (18) 3583-3590
• 26 Samarani M, Loberto N, Soldà G. , et al. A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest. FASEB J 2018; 32 (10) 5685-5702
• 27 Tatti M, Motta M, Di Bartolomeo S. , et al. Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts. Hum Mol Genet 2012; 21 (23) 5159-5173
• 28 Tatti M, Motta M, Di Bartolomeo S, Cianfanelli V, Salvioli R. Cathepsin-mediated regulation of autophagy in saposin C deficiency. Autophagy 2013; 9 (02) 241-243
• 29 Yoneshige A, Muto M, Watanabe T, Hojo H, Matsuda J. The effects of chemically synthesized saposin C on glucosylceramide-β-glucosidase. Clin Biochem 2015; 48 (16–17): 1177-1180